Litcius/Paper detail

Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes

Shariq Qayyum, Taj Mohammad, Radomir M. Slominski, Md. Imtaiyaz Hassan, Robert C. Tuckey, Chander Raman, Andrzej Słomiński

2021American Journal of Physiology-Endocrinology and Metabolism49 citationsDOIOpen Access PDF

Abstract

Active forms of vitamin D and lumisterol can inhibit SARS-CoV-2 replication machinery enzymes, which indicates that novel vitamin D and lumisterol metabolites are candidates for antiviral drug research.

Topics & Concepts

EnzymeCalcitriol receptorViral replicationBiologyBiochemistryVitamin D and neurologyProteaseReverse transcriptaseVirtual screeningVitaminRNADocking (animal)ChemistryDrug discoveryVirologyGeneVirusMedicineNursingEndocrinologyVitamin D Research StudiesComputational Drug Discovery MethodsVitamin C and Antioxidants Research
Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes | Litcius